Dr. Galasko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9350 Campus Point Dr
Perlman Ambulatory Care Center - Neurology
La Jolla, CA 92037Phone+1 858-657-8540Fax+1 858-657-8557
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1984 - 1987
Boston University Medical CenterInternship, Internal Medicine, 1983 - 1984
University of the WitwatersrandClass of 1979
Certifications & Licensure
CA State Medical License 1988 - 2026
MD State Medical License 1985 - 1988
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Anti-Oxidant Treatment of Alzheimer's Disease Start of enrollment: 2006 Jan 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
- Join now to see all
Publications & Presentations
PubMed
- Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.Udit Sheth, Linn Öijerstedt, Michael G Heckman, Launia J White, Hilary W Heuer
Molecular Neurodegeneration. 2025-03-12 - α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease.David G Coughlin, Ben Shifflett, Carly M Farris, Yihua Ma, Douglas Galasko
Neurology. 2025-03-11 - Copy Number Variation and Haplotype Analysis of 17q21.31 Reveals Increased Risk Associated with Progressive Supranuclear Palsy and Gene Expression Changes in Neuronal ...Hui Wang, Timothy S Chang, Beth A Dombroski, Po-Liang Cheng, Ya-Qin Si
Movement Disorders. 2025-03-08
Journal Articles
- A Comprehensive Screening of Copy Number Variability in Dementia with Lewy BodiesEliezer Masliah, Ted Dawson, Nigel J Cairns, John C Morris, Sonja W Scholz, John Q Trojanowski, Liana Rosenthal, Lawrence S Honig, Douglas Galasko, Thomas G Beach, Ron..., ScienceDirect
- Microstructural Brain Changes Track Cognitive Decline in Mild Cognitive ImpairmentJames B Brewer, Christina E Wierenga, Douglas Galasko, ScienceDirect
Press Mentions
Biomarker Test Can Detect Alzheimer's Pathology EarlierFebruary 10th, 2025- New Biomarker Test Detects Early Tau Tangles in Alzheimer's DiseaseFebruary 9th, 2025
- New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in the Blood – Neuroscience NewsDecember 29th, 2022
- Join now to see all
Grant Support
- Dementia with Lewy Bodies ConsortiumCLEVELAND CLINIC LERNER COM-CWRU2016–2027
- Dementia with Lewy Bodies ConsortiumCLEVELAND CLINIC LERNER COM-CWRU2016–2027
- Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2018–2025
- Clinical Core BNational Institute On Aging2009–2012
- Administrative Core ANational Institute On Aging2009–2012
- Alzheimer'S Disease Research CenterNational Institute On Aging2007–2012
- Clinical Studies Of Nsaidss As Y-Secretase Modulators In Alzheimer'S DiseaseNational Institute On Aging2009–2011
- A Trial Of Ttp488 To Slow The Rate Of Clinical Progression Of Patients With ADNational Institute On Aging2006–2010
- Testing The Role Of Axonal Transport Disturbance In AD?National Institute On Aging2007–2008
- Biomarkers In Aging, MCI And Alzheimer'S DiseaseNational Institute On Aging2003–2007
- Age Related Neurodegenerative Diseases In MicronesiaNational Institute On Aging2000–2006
- Prevalence /Incidence /Risk Factors For Dementia On GuamNational Institute On Aging2002
- Core--ClinicalNational Institute On Aging2002
- Core---Administrative, Database, And StatisticalNational Institute On Aging2002
- Clinical Evaluation Of Nsaids As Anti-Amyloid CompoundsNational Institute On Aging2002
- A Phase 1B Study Of Ipa In ADNational Institute On Aging2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
